DaVita
DVA
#1518
Rank
S$14.74 B
Marketcap
$175.74
Share price
0.46%
Change (1 day)
-2.58%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

Revenue for DaVita (DVA)

Revenue in 2024 (TTM): S$17.12 Billion

According to DaVita's latest financial reports the company's current revenue (TTM ) is S$16.79 Billion. an increase over the revenue in the year 2023 that were of S$16.03 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for DaVita from 1996 to 2024

20002005201020152020$5B$10B$15B$20Bcompaniesmarketcap.com

Annual revenue

Year Revenue Change
2024 S$17.41 B8.65%
2023 S$16.03 B3.02%
2022 S$15.56 B-0.91%
2021 S$15.70 B2.79%
2020 S$15.28 B-0.48%
2019 S$15.35 B-1.46%
2018 S$15.58 B7.1%
2017 S$14.54 B-26.79%
2016 S$19.86 B1.92%
2015 S$19.49 B15.31%
2014 S$16.90 B13.43%
2013 S$14.90 B49.82%
2012 S$9.94 B12.25%
2011 S$8.86 B6.75%
2010 S$8.30 B-3.19%
2009 S$8.57 B5.95%
2008 S$8.09 B6.86%
2007 S$7.57 B1.22%
2006 S$7.48 B56.14%
2005 S$4.79 B27.82%
2004 S$3.74 B7.85%
2003 S$3.47 B8.04%
2002 S$3.21 B5.31%
2001 S$3.05 B18.63%
2000 S$2.57 B7.06%
1999 S$2.40 B20.96%
1998 S$1.98 B125.95%
1997 S$0.88 B130.61%
1996 S$0.38 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
S$27.07 B 61.25%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.63 B-84.29%๐Ÿ‡บ๐Ÿ‡ธ USA
S$20.74 B 23.51%๐Ÿ‡บ๐Ÿ‡ธ USA
S$17.04 B 1.51%๐Ÿ‡บ๐Ÿ‡ธ USA